Glaukos Corporation (NYSE: GKOS) is a ophthalmic medical device company that develops and commercializes surgical and pharmaceutical products targeting glaucoma and corneal health conditions. The company generates revenue primarily through the sale of its micro-invasive glaucoma surgery (MIGS) devices and corneal health products to hospitals, ambulatory surgery centers, and eye care professionals. The 10-K filed 2026-02-23 (accession 000119312526061944) covers the fiscal year ended in that cycle, but the filing excerpts provided contain only the cover page and do not disclose segment revenue breakdowns, customer concentration figures, geographic mix, or named competitors. Based solely on the available filing content, Glaukos is incorporated and operates as a publicly traded U.S. medical device company listed on a national exchange under the ticker GKOS, focused on ophthalmic conditions.
Source: SEC 10-K, filed 2026-02-23
Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AtriCure Inc Axonics, Inc. Enovis Corp Conmed Corp Integer Holdings Corp Integra Lifesciences Holdings Corp NUVASIVE INC Procept Biorobotics Corp Tandem Diabetes Care Inc
Loading...